REVENUE MEMORANDUM CIRCULAR NO. 62-2020 issued on June 23, 2020 publishes the “List of Prescription Drugs and Medicines for Diabetes, High-Cholesterol and Hypertension Exempt from VAT Beginning January 27, 2020” provided by the Food and Drug Administration of the Department of Health.